ALung Technologies Receives Health Canada Approval for Hemolung Respiratory Assist System

4 February 2013 Press Release

Company begins commercialization of innovative Respiratory Dialysis® device for acute respiratory failure. PITTSBURGH— ALung Technologies, Inc., a leading developer of innovative respiratory assist devices, announced today that it has received a Health Canada license for its Hemolung Respiratory Assist System (RAS). The Company has initiated commercialization activities worldwide in preparation for a global launch of (read more)

ALung Technologies Presents Positive Clinical Trial Results of the Hemolung Respiratory Assist System

18 June 2012 Press Release

Pilot study shows the potential of the Hemolung RAS to help reduce the need for invasive mechanical ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). PITTSBURGH, Pennsylvania, June 18, 2012 – ALung Technologies, Inc., a leading developer of innovative lung assist devices, presented an analysis of its recent clinical trial of (read more)

ALung Technologies Raises $10M in Series B Financing

6 February 2012 Press Release

PITTSBURGH–(BUSINESS WIRE)–ALung Technologies, Inc., a leading developer of advanced respiratory products, announced today that it has closed a $10 million Series B financing round. The investment will support the continued commercialization of ALung’s flagship product, the Hemolung® Respiratory Assist System (RAS), which provides partial respiratory assistance to patients in acute respiratory failure. The device is expected (read more)